SEP 16, 2015 4:57 PM PDT

Aggressive AML

WRITTEN BY: Ilene Schneider
University of Manchester scientists have identified a gene, FOXC1, that, if turned on, can cause more aggressive cancer in a fifth of acute myeloid leukemia (AML) patients, according to a Cancer Research UK study published in the journal Cancer Cell and reported in Drug Discovery & Development
Gene can make acute myeloid leukemia more aggressive.
The FOXC1 gene is normally turned on during embryonic development. It is needed to turn cells into specialized tissues, like the eyes, kidney, brain and bone, but this new research found that in certain patients with AML, a type of blood cancer that affects white blood cells and the bone marrow, this gene was wrongly turned on inside the patient’s cancer cells.

When it is turned on in blood cell tissue, FOXC1 stunts the development of blood cells and stops them from maturing into normal specialized blood cells. This condition causes the cancer to be more aggressive, because young cells are able to replicate more than mature cells. This, in turn, causes cancer cells to grow faster and become more difficult to treat.

About 2,900 people were diagnosed with AML in the UK in 2011. Of that number, around 20 per cent would have had the FOXC1 gene wrongly turned on in their cancer.

According to Dr Tim Somervaille, lead author from the Cancer Research UK Manchester Institute at The University of Manchester, “This is an important finding which helps us understand how acute myeloid leukemia develops and why some cases of AML are more aggressive than others. Here, instead of being faulty or mutated, this normal gene is turned on in the wrong place at the wrong time which makes the cancer grow more rapidly. There are certain situations where this gene is necessary, as in the development of the eye and skeleton before birth. But when it’s switched on in the wrong tissue, it causes more aggressive forms of leukemia.” 

Nell Barrie, senior science communication manager at Cancer Research UK, added, “It’s essential that we continue to research basic biology to further understand how cells become cancerous. In this study, identifying a specific gene behind more aggressive forms of acute myeloid leukemia could give clues for new ways to personalize treatments for select patients. The better we understand the nuts and bolts of each cancer, the sooner we can find new ways to stop it.”
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
NOV 24, 2019
Genetics & Genomics
NOV 24, 2019
22 Genes Discovered that Predict Skin Cancer from Sun Exposure
Australia has the highest rate of skin cancer in the world, with around 49 cases per 100,000 people. Now, researchers at the QIMR Berghofer Medical Researc...
NOV 25, 2019
Cancer
NOV 25, 2019
Using AI to determine which patients are best suited for immunotherapy
A new study published in the journal Cancer Immunology Research suggests that we can use artificial intelligence to help determine which people with lung c...
JAN 15, 2020
Clinical & Molecular DX
JAN 15, 2020
Laser microchip picks up cancer markers in urine
A future where patients no longer need to endure expensive, painful and complicated cancer tests could soon become a reality. Researchers have developed a...
JAN 14, 2020
Cancer
JAN 14, 2020
Could the flu vaccine shrink cancer tumors?
If you’ve been to the doctor recently, you’ve probably been asked if you want a flu shot this year. The flu vaccine is popular because it reduc...
JAN 17, 2020
Cancer
JAN 17, 2020
Could salt nanoparticles kill cancer?
Could salt be the key to killing cancer cells? A new study published in Advanced Materials reports success in using sodium chloride to destroy cancer cells...
FEB 02, 2020
Cancer
FEB 02, 2020
These cosmetics damage breast cells' DNA
A new approach to studying the effects of two common chemicals used in cosmetics and sunscreens found they can cause DNA damage in breast cells at surprisi...
Loading Comments...